A pilot study to evaluate MN-166 (ibudilast) in chemotherapy-induced peripheral neuropathy
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2018
At a glance
- Drugs Ibudilast (Primary)
- Indications Peripheral neuropathies
- Focus Therapeutic Use
- 04 Apr 2018 New trial record
- 28 Mar 2018 According to a MediciNova media release, a Concord Cancer Centre Research grant will provide funding for this study and MediciNova will provide study drug.
- 28 Mar 2018 According to a MediciNova media release, the clinical trial is a collaborative effort between MediciNova and Dr. Janette Vardy (the Principal Investigator for this study), Professor of Cancer Medicine, University of Sydney Concord Cancer Centre in Australia.